CYCC logo

Cyclacel Pharmaceuticals (CYCC)

Profile

Full Name

Cyclacel Pharmaceuticals, Inc.

Ticker Symbol

CYCC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Malaysia

IPO

March 16, 2004

Indexes

Not included

Website

http://www.cyclacel.com

Employees

12

Key Details

Price

$0.25(-27.09%)

Market cap

Last Dividend

$2.40

TTM Dividend yield

968.13%

Annual revenue

$43.00K(-89.76% YoY)

Annual EPS

-$33.44(+92.19% YoY)

PE ratio

-

Next earnings date

Aug 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.25
    CYCC price is $0.25

    30-Day Relative Volume

    1.49
    CYCC 30-day relative volume is 1.49

    Price Performance

    Price Most recent change

    -27.09%
    CYCC price was down -27.09% on Jul 2, 2025

    Price YTD change

    -95.92%
    CYCC price is down -95.92% since January 1st

    Price 1-year change

    -99.07%
    CYCC price is down -99.07% year-on-year

    Price 3-year change

    -99.91%
    CYCC price is down -99.91% over the past 3 years

    Price Range

    Price All-time high

    $34272000.00
    CYCC price is currently -100.00% below its historical high of $34272000.00

    Price 3-year low

    $0.23
    CYCC price is currently +7.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.89M
    CYCC market capitalization is $5.89 million

    Market cap 3-year change

    -53.26%
    CYCC market capitalization is down -53.26% over the past 3 years

    Market cap All-time high

    $358.85M
    CYCC market capitalization is currently -98.36% below its historical high of $358.85 million

    Market cap sector rank

    12.85%
    CYCC market capitalization is higher than 12.85% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +20963.39%
    CYCC shares outstanding is up +20963.39% year-on-year

    Shares Outstanding 3-Year Change

    +50131.5%
    CYCC shares outstanding is up +50131.5% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.49
    CYCC beta is 0.49

    200-day SMA

    $6.32
    CYCC price is currently -96.07% below its 200-day simple moving average

    50-day SMA

    $2.01
    CYCC price is currently -87.66% below its 50-day simple moving average

    RSI

    24.52
    CYCC 14-day relative strength index is 24.52

    Volume

    1.49
    CYCC 30-day relative volume is 1.49

    ATR

    $0.13
    CYCC average true range is $0.13

    10-day Historical Volatility

    150.20%
    CYCC 10-day historical volatility is 150.20%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $2.40
    CYCC last dividend was $2.40 per share, with an ex-dividend date of April 29, 2025

    Next Dividend

    -
    CYCC next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    CYCC annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    CYCC annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    CYCC annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    CYCC annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    CYCC annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    CYCC annual dividend yield is unknown

    Other

    Payout ratio

    0.00%
    CYCC annual payout ratio is 0.00%

    Dividends paid

    $0.00
    CYCC annual dividends paid is $0.00

    Free cash flow

    -$7.99M
    CYCC annual free cash flow is -$7.99 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $43.00K
    CYCC annual revenue is $43.00 thousand

    Revenue Analysts estimate

    $100.00K
    CYCC annual revenue is currently -57.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    -89.76%
    CYCC annual revenue is down -89.76% year-on-year

    Revenue Sector rank

    3.73%
    CYCC annual revenue is higher than 3.73% of companies in Healthcare sector

    EPS

    EPS

    -$33.44
    CYCC annual earnings per share is -$33.44

    EPS Analysts estimate

    -$1.18
    CYCC annual earnings per share is currently +2733.90% higher than the consensus analysts' forecast

    EPS 1-year change

    +92.19%
    CYCC annual earnings per share is up +92.19% year-on-year

    EPS Sector rank

    5.11%
    CYCC annual earnings per share is higher than 5.11% of companies in Healthcare sector

    Profit

    Gross profit

    -
    CYCC annual gross profit value is unknown

    Gross margin

    -
    CYCC annual gross profit margin value is unknown

    Operating profit

    -$12.00M
    CYCC annual operating income is -$12.00 million

    Operating margin

    -27.92K%
    CYCC annual operating profit margin is -27.92 thousand%

    Net income

    -$11.21M
    CYCC annual net profit is -$11.21 million

    Net margin

    -26.07K%
    CYCC annual net profit margin is -26.07 thousand%

    Expenses

    Total expenses

    $12.05M
    CYCC annual total expenses is $12.05 million

    Operating expenses

    $12.05M
    CYCC annual total operating expenses is $12.05 million

    Cost of goods sold

    -
    CYCC annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $5.39M
    CYCC annual SGA is $5.39 million

    Depreciation and amortization

    $6000.00
    CYCC annual depreciation & amortization is $6000.00

    Interest expense

    -
    CYCC annual interest expense value is unknown

    Income tax

    -$782.00K
    CYCC annual income tax is -$782.00 thousand

    EBIT & EBITDA

    EBIT

    -$12.00M
    CYCC annual earnings before interest & taxes is -$12.00 million

    EBITDA

    -$12.00M
    CYCC annual EBITDA is -$12.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.09M
    CYCC annual total assets is $4.09 million

    Non current assets

    $419.00K
    CYCC annual long term assets is $419.00 thousand

    Current assets

    $3.67M
    CYCC annual total current assets is $3.67 million

    Cash and cash equivalents

    $3.14M
    CYCC annual cash & cash equivalents is $3.14 million

    Accounts receivable

    -
    CYCC annual accounts receivable value is unknown

    Inventory

    -
    CYCC annual inventory value is unknown

    Liabilities

    Total liabilities

    $6.27M
    CYCC annual total liabilities is $6.27 million

    Long term liabilities

    $0.00
    CYCC annual total long term liabilities is $0.00

    Current liabilities

    $6.27M
    CYCC annual total current liabilities is $6.27 million

    Accounts payable

    $4.60M
    CYCC annual accounts payable is $4.60 million

    Debt

    Total debt

    $0.00
    CYCC annual total debt is $0.00

    Total debt 1-year change

    -100%
    CYCC annual total debt is down -100% year-on-year

    Long term debt

    $0.00
    CYCC annual long term debt is $0.00

    Short term debt

    -
    CYCC annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    -$2.17M
    CYCC annual stockholders equity is -$2.17 million

    Book value

    -$2.17M
    CYCC annual book value is -$2.17 million

    Retained earnings

    -$439.49M
    CYCC annual retained earnings is -$439.49 million

    Working capital

    -$2.59M
    CYCC annual working capital is -$2.59 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$7.99M
    CYCC annual cash flow from operations is -$7.99 million

    Cash from operations 1-year change

    +50.41%
    CYCC annual cash flow from operations is up +50.41% year-on-year

    Cash from investing

    $0.00
    CYCC annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    +100%
    CYCC annual cash flow from investing activities is up +100% year-on-year

    Cash from financing

    $7.82M
    CYCC annual cash flow from financing activities is $7.82 million

    Cash from financing 1-year change

    +822.41%
    CYCC annual cash flow from financing activities is up +822.41% year-on-year

    CAPEX

    CAPEX

    -
    CYCC annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    CYCC annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$7.99M
    CYCC annual free cash flow is -$7.99 million

    Free cash flow 1-year change

    +50.43%
    CYCC annual free cash flow is up +50.43% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CYCC annual gross profit margin value is unknown

    Operating margin

    -27.92K%
    CYCC annual operating profit margin is -27.92 thousand%

    Net margin

    -26.07K%
    CYCC annual net profit margin is -26.07 thousand%

    ROA & ROE

    ROA

    -173.84%
    CYCC annual return on assets is -173.84%

    ROE

    515.73%
    CYCC annual return on equity is 515.73%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CYCC price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CYCC price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.92
    CYCC price to book ratio is 1.92

    PB ratio Sector rank

    56.51%
    CYCC price to book ratio is higher than 56.51% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CYCC price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CYCC price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $2.45M
    CYCC enterprise value is $2.45 million

    Enterprise value Sector rank

    15.18%
    CYCC enterprise value is higher than 15.18% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.19
    CYCC EV/EBITDA is -0.19

    EV/EBITDA Sector rank

    61.24%
    CYCC EV/EBITDA is higher than 61.24% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.59
    CYCC annual current ratio is 0.59

    Quick ratio

    -
    CYCC annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    CYCC annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CYCC annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CYCC piotroski f-score value is unknown

    Altman Z-Score

    -160.15
    CYCC altman z-score is -160.15

    Analyst ratings

    Recent major analysts updates

    May 3, 24 Roth MKM
    Buy
    Dec 19, 23 Roth MKM
    Buy
    Dec 19, 23 Brookline Capital
    Hold
    May 25, 23 Oppenheimer
    Outperform
    Mar 7, 23 Oppenheimer
    Outperform
    Apr 30, 21 Oppenheimer
    Outperform
    Nov 25, 20 Roth Capital
    Buy
    Nov 25, 20 JMP Securities
    Market Outperform
    Nov 25, 20 H.C. Wainwright
    Buy
    Sep 5, 18 Roth Capital
    Buy

    Institutional Ownership

    Screeners with CYCC included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    High yield dividend stocks
    NASDAQ Listed Companies
    Stocks with all time high dividends
    • What is the ticker symbol for Cyclacel Pharmaceuticals?
    • Does Cyclacel Pharmaceuticals pay dividends?
    • What sector is Cyclacel Pharmaceuticals in?
    • What industry is Cyclacel Pharmaceuticals in?
    • What country is Cyclacel Pharmaceuticals based in?
    • When did Cyclacel Pharmaceuticals go public?
    • Is Cyclacel Pharmaceuticals in the S&P 500?
    • Is Cyclacel Pharmaceuticals in the NASDAQ 100?
    • Is Cyclacel Pharmaceuticals in the Dow Jones?
    • When was Cyclacel Pharmaceuticals's last earnings report?
    • When does Cyclacel Pharmaceuticals report earnings?
    • Should I buy Cyclacel Pharmaceuticals stock now?

    What is the ticker symbol for Cyclacel Pharmaceuticals?

    The ticker symbol for Cyclacel Pharmaceuticals is NASDAQ:CYCC

    Does Cyclacel Pharmaceuticals pay dividends?

    Yes, Cyclacel Pharmaceuticals pays dividends. The last payment was $2.40, with an ex-dividend date on April 29, 2025

    What sector is Cyclacel Pharmaceuticals in?

    Cyclacel Pharmaceuticals is in the Healthcare sector

    What industry is Cyclacel Pharmaceuticals in?

    Cyclacel Pharmaceuticals is in the Biotechnology industry

    What country is Cyclacel Pharmaceuticals based in?

    Cyclacel Pharmaceuticals is headquartered in Malaysia

    When did Cyclacel Pharmaceuticals go public?

    Cyclacel Pharmaceuticals's initial public offering (IPO) was on March 16, 2004

    Is Cyclacel Pharmaceuticals in the S&P 500?

    No, Cyclacel Pharmaceuticals is not included in the S&P 500 index

    Is Cyclacel Pharmaceuticals in the NASDAQ 100?

    No, Cyclacel Pharmaceuticals is not included in the NASDAQ 100 index

    Is Cyclacel Pharmaceuticals in the Dow Jones?

    No, Cyclacel Pharmaceuticals is not included in the Dow Jones index

    When was Cyclacel Pharmaceuticals's last earnings report?

    Cyclacel Pharmaceuticals's most recent earnings report was on May 15, 2025

    When does Cyclacel Pharmaceuticals report earnings?

    The next expected earnings date for Cyclacel Pharmaceuticals is Aug 14, 2025

    Should I buy Cyclacel Pharmaceuticals stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page